Insider

Baker entities obtained 7.8% voting power over BeOne Medicines Ltd. shares

Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Felix J. Baker and Julian C. Baker each reported holding 115,457,154 (LP and GP) or 115,912,814 (Felix and Julian) shares, representing 7.8% voting power in the BeOne Medicines Ltd. class, in a filing dated September 14, 2026.

Verified against 5 archived primary sources · SHA-256 recorded Inspect sources & citations ↓
white and red exit sign
Photo by Cory Mogk on Unsplash
7.8%
Voting power
115,457,154 shares
Shares owned
1,115 ADS
Proposed sale

Key points

  • Baker Bros.
  • A checked box in the Rule 10b5‑1 field does not prove the absence of a trading plan, and a notice of intent to sell shares is only an intention and does not indicate an actual transaction at this time.

What happened

Baker Bros. Advisors LP and Baker Bros. Advisors (GP) LLC have sole voting and dispositive power over 115,457,154 shares, while Felix J. Baker and Julian C. Baker have it over 115,912,814 shares; each controls 7.8% of the BeOne Medicines Ltd. class.

Director and chair of the Scientific Advisory Board Wang Xiaodong, in an insider‑trade filing dated September 28, 2026, bought 31,028 shares at an average price of $36.9 and immediately sold them on the open market for $364.7853 per share; he also sold 403,364 derivative securities, retaining 806,715.

Officer Chan Lee filed a notice of intended sale reporting a planned disposition of 1,115 ADS (American Depositary Shares) with an approximate date of September 30, 2026; the shares were acquired on July 29, 2022 as RSUs, and the trading plan was approved on May 29, 2026.

Lee Chan Henry, senior vice president and general counsel, in an insider‑trade filing for September 30, 2026, sold 1,115 ADS at an average price of $375 under Rule 10b5‑1, leaving zero shares after the sale.

Value of shares sold, by insider

Lee Chan Henry$418,125Wang Xiaodong$11,318,557.97
Data from the original sources listed alongside.

What this does not mean

A checked box in the Rule 10b5‑1 field does not prove the absence of a trading plan, and a notice of intent to sell shares is only an intention and does not indicate an actual transaction at this time.

Original sources

  1. SCHEDULE 13D/A filing, September 16, 2026September 16, 2026SHA-256 of our archived copy 3deb4b875ee7…
  2. 4 filing, September 16, 2026September 16, 2026SHA-256 of our archived copy 45a84d9992f6…
  3. 4 filing, September 30, 2026September 30, 2026SHA-256 of our archived copy 1f569b3c2fdf…
  4. 144 filing, September 30, 2026September 30, 2026SHA-256 of our archived copy 5341dcce57d3…
  5. 4 filing, October 2, 2026October 2, 2026SHA-256 of our archived copy 24df2866fe5a…
Cite this article

The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.

Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards